Meet Liz O'Day, CEO of Olaris Therapeutics, a precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
top of page
bottom of page
Meet Liz O'Day, CEO of Olaris Therapeutics, a precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.
Comments